- Home
- OABI vs MFM Comparison
OABI vs MFM Comparison
Compare OABI & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- MFM
- Stock Information
- Founded
- OABI 2012
- MFM 1986
- Country
- OABI United States
- MFM United States
- Employees
- OABI N/A
- MFM N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- MFM Finance Companies
- Sector
- OABI Health Care
- MFM Finance
- Exchange
- OABI Nasdaq
- MFM Nasdaq
- Market Cap
- OABI 250.8M
- MFM 212.1M
- IPO Year
- OABI N/A
- MFM N/A
- Fundamental
- Price
- OABI $2.06
- MFM $5.08
- Analyst Decision
- OABI Strong Buy
- MFM
- Analyst Count
- OABI 3
- MFM 0
- Target Price
- OABI $7.00
- MFM N/A
- AVG Volume (30 Days)
- OABI 545.9K
- MFM 108.1K
- Earning Date
- OABI 08-06-2025
- MFM 01-01-0001
- Dividend Yield
- OABI N/A
- MFM 4.08%
- EPS Growth
- OABI N/A
- MFM N/A
- EPS
- OABI N/A
- MFM 0.03
- Revenue
- OABI $26,744,000.00
- MFM N/A
- Revenue This Year
- OABI N/A
- MFM N/A
- Revenue Next Year
- OABI $45.02
- MFM N/A
- P/E Ratio
- OABI N/A
- MFM $176.67
- Revenue Growth
- OABI 27.07
- MFM N/A
- 52 Week Low
- OABI $1.22
- MFM $4.37
- 52 Week High
- OABI $4.95
- MFM $5.48
- Technical
- Relative Strength Index (RSI)
- OABI 59.11
- MFM 45.66
- Support Level
- OABI $1.90
- MFM $5.14
- Resistance Level
- OABI $2.19
- MFM $5.15
- Average True Range (ATR)
- OABI 0.13
- MFM 0.05
- MACD
- OABI -0.00
- MFM -0.00
- Stochastic Oscillator
- OABI 40.51
- MFM 25.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.